TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7131542

Group type: EXPERIMENTAL
Intervention: Educational materials (posters, recipes, brochures) placed in the dairy section for 6 months
Number of subjects: 8

Group type: COMPARATOR
Intervention: No educational materials (control condition)
Number of subjects: 8
Study: 30630533

Group type: EXPERIMENTAL
Intervention: CT data-based 3D pelvic model measurement of pelvic incidence (PI)
Number of subjects: 320
Study: 30389581

Group type: EXPERIMENTAL
Intervention: Dancing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stretching (active control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups (Dancing, Walking, Stretching)
Number of subjects: 30
Study: 26845715

Group type: EXPERIMENTAL
Intervention: Oral propranolol (0.5 mg/kg/dose q8h)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Historic control group
Number of subjects: 47
Study: 24934009

Group type: EXPERIMENTAL
Intervention: Collaborative interactive groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nominal groups
Number of subjects: 0
Study: 22494488

Group type: EXPERIMENTAL
Intervention: Pinto beans/rice
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Black beans/rice
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Red kidney beans/rice
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rice alone (control)
Number of subjects: 17
Study: 21048536

Group type: COMPARATOR
Intervention: Steroid group (n=54)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppression
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Steroid-free group (n=56)
Number of subjects: 110

Group type: COMPARATOR
Intervention: HCV patients
Number of subjects: 110

Group type: COMPARATOR
Intervention: Steroid bolus therapy
Number of subjects: 110
Study: 17932357

Group type: EXPERIMENTAL
Intervention: Ibuprofen use (yes)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Age at diagnosis (≥65 versus <65)
Number of subjects: 377
Study: 16320746

Group type: EXPERIMENTAL
Intervention: Acupuncture plus drug (group D)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Electroacupuncture (group B)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Drug (group C)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Electroacupuncture plus drug (group E)
Number of subjects: 477
Study: 12220425

Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy with diaphragm opening
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy without diaphragm opening
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transhiatal esophagectomy (both groups)
Number of subjects: 20
Study: 11922399

Group type: EXPERIMENTAL
Intervention: Cizolirtine 200 mg administered twice daily for 21 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo administered twice daily for 21 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cizolirtine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9550651

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) induction
Number of subjects: 89
Study: 8311269

Group type: EXPERIMENTAL
Intervention: Fentanyl 5 micrograms/kg combined with thiopental 3 mg/kg, maintained with isoflurane and fentanyl 0.02 microgram.kg‐1.min‐1
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ketamine 2 mg/kg combined with thiopental 3 mg/kg, maintained with isoflurane and ketamine 20 micrograms.kg‐1.min‐1
Number of subjects: 27

Group type: COMPARATOR
Intervention: Thiopental 5 mg/kg, maintained with isoflurane only
Number of subjects: 27
Study: 3353456

Group type: EXPERIMENTAL
Intervention: Supervised home exercise program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control Group (no exercise program)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Symptom-limited multistage step test
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chronic Respiratory Disease Questionnaire
Number of subjects: 14
Study: 5303551

Group type: EXPERIMENTAL
Intervention: Unbuffered aspirin ingestion with alcohol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 20
Study: 392094

Group type: EXPERIMENTAL
Intervention: Naproxen 125 mg b.i.d.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg b.i.d.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg b.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Corticosteroids (prednisone)
Number of subjects: 50
Study: 30185239

Group type: EXPERIMENTAL
Intervention: web-based CBT-I
Number of subjects: 56

Group type: COMPARATOR
Intervention: waiting-list control
Number of subjects: 56
Study: 30006474

Group type: EXPERIMENTAL
Intervention: E-Counseling
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control
Number of subjects: 264
Study: 27455604

Group type: EXPERIMENTAL
Intervention: Standard diet plus two drinks per day containing 4 g inulin, 4 mg menthol, and 2 mg pyridoxine for 2 weeks
Number of subjects: 49
Study: 24369301

Group type: EXPERIMENTAL
Intervention: SUCCEED (six-month lifestyle intervention)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 75
Study: 21440444

Group type: EXPERIMENTAL
Intervention: Retransfusion Drain
Number of subjects: 48

Group type: COMPARATOR
Intervention: No Drain
Number of subjects: 48
Study: 21047432

Group type: EXPERIMENTAL
Intervention: Basic online weight-loss program
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Enhanced online weight-loss program
Number of subjects: 3

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Maintenance basic program
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Maintenance enhanced program
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3
Study: 15578008

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and CBASP
Number of subjects: 0
Study: 11820489

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10430731

Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 0.5 mg/kg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 1 mg/kg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled low-molecular-weight heparin (enoxaparin) 2 mg/kg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled unfractionated heparin (7.5 mg/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13
Study: 7985890

Group type: EXPERIMENTAL
Intervention: Levothyroxine (thyroid‐stimulating hormone level, < 0.3 mU/L)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Potassium iodide (2 mg every 2 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 80
Study: 2111415

Group type: EXPERIMENTAL
Intervention: MMC + FT + Bestatin
Number of subjects: 96

Group type: COMPARATOR
Intervention: MMC + FT
Number of subjects: 96
Study: 6778352

Group type: EXPERIMENTAL
Intervention: Halothane with nitrous oxide (N2O)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Halothane without nitrous oxide (N2O)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Assisted ventilation during mask inhalation anesthetic techniques
Number of subjects: 69
Study: 31808611

Group type: EXPERIMENTAL
Intervention: Deep lamellar dissection (scleral flap excision)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vertical cut‐down incision
Number of subjects: 32
Study: 28724370

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural and psychoeducational intervention (five sessions, four hours each)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 26296850

Group type: EXPERIMENTAL
Intervention: Dark chocolate (49 g/day) during reduced snack consumption
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (reduced snacks only)
Number of subjects: 22
Study: 25108751

Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (8 treatments)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (12 treatments)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chiropractic flexion-distraction manipulation (18 treatments)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo care (8 treatments)
Number of subjects: 60
Study: 21964953

Group type: EXPERIMENTAL
Intervention: 10-week service learning activities
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 124
Study: 19608997

Group type: EXPERIMENTAL
Intervention: Thalidomide (100-200 mg daily for up to 2 years)
Number of subjects: 724

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 724
Study: 17844713

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombolytic therapy followed by transfer for PCI
Number of subjects: 0
Study: 15354209

Group type: EXPERIMENTAL
Intervention: IM862 (20 mg intranasally three times daily for 8 weeks)
Number of subjects: 25
Study: 12398962

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg/day
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Celecoxib 200 mg/day
Number of subjects: 1092
Study: 10423978

Group type: EXPERIMENTAL
Intervention: Interventions consistent with corresponding RCT data
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Interventions in cardiology, stroke/angiology, and gastroenterology
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Interventions in endocrinology, nephrology, haematology, and oncology
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Management of patients presenting with symptoms only, without a specific diagnosis
Number of subjects: 197
Study: 8835086

Group type: EXPERIMENTAL
Intervention: Dobutamine (10 micrograms/kg/min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dopamine (10 micrograms/kg/min)
Number of subjects: 20
Study: 2351001

Group type: EXPERIMENTAL
Intervention: 0.5 percent bupivacaine (1.5 mg/kg) in adrenaline solution (1:200,000)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Adrenaline solution (control)
Number of subjects: 40
Study: 356306

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (10 mg/kg, three doses: upon admission, 8 hours, and 16 hours post-trauma)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 60
Study: 29437598

Group type: EXPERIMENTAL
Intervention: Bilateral TENS+TOT
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unilateral TENS+TOT
Number of subjects: 80
Study: 27876031

Group type: EXPERIMENTAL
Intervention: NEXit intervention (text messaging-based smoking cessation programme)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 289
Study: 25407464

Group type: EXPERIMENTAL
Intervention: Single MDA with azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual MDA with azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 0
Study: 23359969

Group type: EXPERIMENTAL
Intervention: Suxiao Jiuxin Pill (SJP) and Western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 60
Study: 20374661

Group type: EXPERIMENTAL
Intervention: Telephone-delivered lifestyle intervention promoting healthy weight and physical activity (4 sessions over 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (previously proven physical activity intervention, 2 sessions over 6 weeks)
Number of subjects: 0
Study: 17652708

Group type: EXPERIMENTAL
Intervention: 1.0% azithromycin in DuraSite (n = 365)
Number of subjects: 743

Group type: COMPARATOR
Intervention: 0.3% tobramycin (n = 378)
Number of subjects: 743
Study: 16105793

Group type: EXPERIMENTAL
Intervention: Elective induction of labor (IND)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Elective induction of labor (IND) for nulliparous patients
Number of subjects: 226

Group type: COMPARATOR
Intervention: Expectant management (EM) for nulliparous patients
Number of subjects: 226
Study: 12105285

Group type: EXPERIMENTAL
Intervention: Bupropion SR 300 mg/d
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Bupropion SR 400 mg/d
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 10457876

Group type: EXPERIMENTAL
Intervention: Light-guided tracheal intubation using a prototype illuminated flexible catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Blind tracheal intubation through the intubating laryngeal mask
Number of subjects: 100
Study: 7794581

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 2171046

Group type: EXPERIMENTAL
Intervention: Peptide histidine valine (PHV) infusion
Number of subjects: 4

Group type: COMPARATOR
Intervention: Atenolol (beta-blocker)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 387279

Group type: EXPERIMENTAL
Intervention: Adriamycin-DNA (ADM-DNA)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Daunorubicin-DNA (DNR-DNA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Daunorubicin (DNR)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Adriamycin (ADM)
Number of subjects: 69
Study: 31221493

Group type: EXPERIMENTAL
Intervention: Chiropractic manipulation
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Patient record scanning
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Training clinic staff
Number of subjects: 2024
Study: 27989730

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention targeting physical activity over a 3-month period.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 40
Study: 25059694

Group type: EXPERIMENTAL
Intervention: Early endovascular aneurysm treatment within 24 hours of randomization
Number of subjects: 14

Group type: COMPARATOR
Intervention: Treatment after neurologic recovery
Number of subjects: 14
Study: 23349099

Group type: EXPERIMENTAL
Intervention: Glutathione (used for in vitro reduction of ovomucoid)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Reduced ovomucoid
Number of subjects: 19
Study: 21216083

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for three years
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cetirizine for three years
Number of subjects: 68

Group type: COMPARATOR
Intervention: Passive smoking exposure
Number of subjects: 68
Study: 19504120

Group type: EXPERIMENTAL
Intervention: 30 min repetitive work (RW)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 min repetitive work with superimposed mental load (RWML)
Number of subjects: 15
Study: 16496196

Group type: EXPERIMENTAL
Intervention: Older adults (14); 20% MVC, constant force condition
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Older adults (14); 40% MVC, constant force condition
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Older adults (14); sinusoidal force condition
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Older adults (14); digit force sharing
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Older adults (14); cross-correlation analyses
Number of subjects: 27

Group type: COMPARATOR
Intervention: Young adults (13); 20% MVC, constant force condition
Number of subjects: 27

Group type: COMPARATOR
Intervention: Young adults (13); 40% MVC, constant force condition
Number of subjects: 27

Group type: COMPARATOR
Intervention: Young adults (13); sinusoidal force condition
Number of subjects: 27

Group type: COMPARATOR
Intervention: Young adults (13); digit force sharing
Number of subjects: 27

Group type: COMPARATOR
Intervention: Young adults (13); cross-correlation analyses
Number of subjects: 27
Study: 14579083

Group type: EXPERIMENTAL
Intervention: Heliprobe method (14C-urea breath test)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Standard method (14C-urea breath test)
Number of subjects: 75

Group type: COMPARATOR
Intervention: CLO test
Number of subjects: 75
Study: 11090597

Group type: EXPERIMENTAL
Intervention: Fat-adapt
Number of subjects: 8

Group type: COMPARATOR
Intervention: HCHO
Number of subjects: 8
Study: 9421820

Group type: EXPERIMENTAL
Intervention: Parallelogram goniometer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Universal goniometer
Number of subjects: 60
Study: 7827834

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg intramuscular
Number of subjects: 154

Group type: COMPARATOR
Intervention: Pethidine 100 mg intramuscular
Number of subjects: 154
Study: 3059842

Group type: EXPERIMENTAL
Intervention: 2% lignocaine with 1/200,000 adrenaline
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% plain bupivacaine
Number of subjects: 60
Study: 29178284

Group type: EXPERIMENTAL
Intervention: Nitric oxide inhalations (160 ppm for 30 min, 5 times/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (oxygen/air)
Number of subjects: 43
Study: 26290001

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Wait-list comparison group
Number of subjects: 158
Study: 23276249

Group type: EXPERIMENTAL
Intervention: Mini-laparoscopic cholecystectomy (MLC)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (LC)
Number of subjects: 41
Study: 20806100

Group type: EXPERIMENTAL
Intervention: EndoVac for 210 seconds
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EndoVac for 150 seconds
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional positive-pressure irrigation for 210 seconds
Number of subjects: 50
Study: 18812629

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg 30 min prior to ASA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: L-tryptophan (0.5 g 30 min prior to ASA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Aspirin (2 x 1 g daily)
Number of subjects: 21
Study: 15883439

Group type: EXPERIMENTAL
Intervention: Step I diet supplemented with soy food (SFD; 50 mg isoflavones/d)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Very-low-fat diet (VLFD; 11% of energy as fat)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control Step I diet (CD; 27% of energy as fat)
Number of subjects: 57
Study: 12932663

Group type: EXPERIMENTAL
Intervention: Refined definition of melanoma ulceration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized pathology worksheet for reporting primary melanomas
Number of subjects: 0
Study: 11279318

Group type: EXPERIMENTAL
Intervention: Nitrates
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Nontreatment
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: Nitrates (in Killip class II‐IV patients)
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Nontreatment (in Killip class II‐IV patients)
Number of subjects: 1303
Study: 8600428

Group type: EXPERIMENTAL
Intervention: 0.01% tropicamide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (young and older subjects)
Number of subjects: 40
Study: 1720478

Group type: EXPERIMENTAL
Intervention: Isradipine (1.25 mg or 2.5 mg twice daily)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg or 25 mg twice daily)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Combination of isradipine and captopril
Number of subjects: 231
Study: 7326194

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (CP) 2 mg injection
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no immune stimulation)
Number of subjects: 43
Study: 30329136

Group type: EXPERIMENTAL
Intervention: Individualized monthly coaching by a physical therapist to adhere to 30 minutes of daily physical activity and 45 minutes of weekly exercise over 18 months
Number of subjects: 186
Study: 28466419

Group type: EXPERIMENTAL
Intervention: Neck-Shoulder Resistance Exercise (NSRE)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional Stretching and Postural Exercise (SPE)
Number of subjects: 35
Study: 25498738

Group type: EXPERIMENTAL
Intervention: DVD-based intervention for stroke self-management over 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 20
Study: 22858517

Group type: EXPERIMENTAL
Intervention: 10-day concomitant therapy comprising esomeprazole 40 mg, amoxicillin 1000 mg, clarithromycin 500 mg, and metronidazole 500 mg, all bid
Number of subjects: 257

Group type: COMPARATOR
Intervention: 10-day standard triple therapy comprising esomeprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, all bid
Number of subjects: 257
Study: 21475971

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.65 g/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-alcoholic placebo beverage
Number of subjects: 64
Study: 19994685

Group type: EXPERIMENTAL
Intervention: Dog-day acupuncture and tortoise-shell moxibustion combined with pelvic floor muscle exercises
Number of subjects: 71

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercises
Number of subjects: 71
Study: 17848493

Group type: EXPERIMENTAL
Intervention: Diet plus pravastatin
Number of subjects: 8214

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 8214
Study: 14991092

Group type: EXPERIMENTAL
Intervention: Standard medical treatment plus CPAP
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard medical treatment alone
Number of subjects: 89
Study: 11574419

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body wt)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 9
Study: 9535249

Group type: EXPERIMENTAL
Intervention: PFP/PFP vaccine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline/PFP vaccine
Number of subjects: 29
Study: 7912767

Group type: EXPERIMENTAL
Intervention: Daily enteric-coated aspirin 300 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3281173

Group type: EXPERIMENTAL
Intervention: Fenfluramine (60 mg p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Arginine infusion (25 g i.v. for 30 min)
Number of subjects: 10